Evidence map›Paper›PMID 31110603›Full record

ReviewWorld journal of stem cells2019

Application of mesenchymal stem cell therapy for the treatment of osteoarthritis of the knee: A concise review.

Ai-Tong Wang, Ying Feng, Hong-Hong Jia, Meng Zhao, Hao Yu

Open access · bronzeAbstract readReview
In one paragraph

Review in World journal of stem cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 4 pooled it
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 4 syntheses or guidelines pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review.International journal of molecular sciences · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ai-Tong WangCell Products of National Engineering Research Center, National Stem Cell Engineering Research Center, Tianjin 300457, China.
Ying FengCell Products of National Engineering Research Center, National Stem Cell Engineering Research Center, Tianjin 300457, China.
Hong-Hong JiaCell Products of National Engineering Research Center, National Stem Cell Engineering Research Center, Tianjin 300457, China.
Meng ZhaoCell Products of National Engineering Research Center, National Stem Cell Engineering Research Center, Tianjin 300457, China.
Hao YuCell Products of National Engineering Research Center, National Stem Cell Engineering Research Center, Tianjin 300457, China. yuhao@amcellgene.com.
Cell Technology (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) refers to a chronic joint disease characterized by degenerative changes of articular cartilage and secondary bone hyperplasia. Since articular cartilage has a special structure, namely the absence of blood vessels as well as the low conversion rate of chondrocytes in the cartilage matrix, the treatment faces numerous clinical challenges. Traditional OA treatment (

Indexed as

Clinical trialsMesenchymal stem cellsOsteoarthritisStem cell therapy

Identifiers

PMID31110603
PMCPMC6503460
OpenAlexW2940589092

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.